Nalaganje...
Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis
BACKGROUND: Mucosal sites are hypothesized to play a role in the development of rheumatoid arthritis (RA). Since serum anti-peptidylarginine deiminase (PAD)4 antibodies, including a subset that cross-react with PAD3 (PAD3/4), are specific for RA and associate with severe disease, we sought to examin...
Shranjeno v:
| izdano v: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8182933/ https://ncbi.nlm.nih.gov/pubmed/34092252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-021-02528-5 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|